99 related articles for article (PubMed ID: 19752884)
1. MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome.
Cizmarikova M; Wagnerova M; Schonova L; Habalova V; Kohut A; Linkova A; Sarissky M; Mojzis J; Mirossay L; Mirossay A
Pharmacogenomics J; 2010 Feb; 10(1):62-9. PubMed ID: 19752884
[TBL] [Abstract][Full Text] [Related]
2. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.
Kafka A; Sauer G; Jaeger C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Int J Oncol; 2003 May; 22(5):1117-21. PubMed ID: 12684679
[TBL] [Abstract][Full Text] [Related]
4. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
Taheri M; Mahjoubi F; Omranipour R
Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
[TBL] [Abstract][Full Text] [Related]
5. A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women.
Zubor P; Lasabova Z; Hatok J; Stanclova A; Danko J
Oncol Rep; 2007 Jul; 18(1):211-7. PubMed ID: 17549370
[TBL] [Abstract][Full Text] [Related]
6. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
7. A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer.
George J; Dharanipragada K; Krishnamachari S; Chandrasekaran A; Sam SS; Sunder E
Clin Breast Cancer; 2009 Aug; 9(3):161-5. PubMed ID: 19661039
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
9. mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy.
Gréen H; Söderkvist P; Rosenberg P; Horvath G; Peterson C
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):854-9. PubMed ID: 16467099
[TBL] [Abstract][Full Text] [Related]
10. Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy.
Henríquez-Hernández LA; Murias-Rosales A; González-Hernández A; de León AC; Díaz-Chico N; Fernández-Pérez L
Cancer Epidemiol; 2010 Oct; 34(5):634-8. PubMed ID: 20638924
[TBL] [Abstract][Full Text] [Related]
11. Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence.
Benyamina A; Bonhomme-Faivre L; Picard V; Sabbagh A; Richard D; Blecha L; Rahioui H; Karila L; Lukasiewicz M; Farinotti R; Picard V; Marill C; Reynaud M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1270-4. PubMed ID: 19625010
[TBL] [Abstract][Full Text] [Related]
12. The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations.
Dong Q; Xu B; Tan Y; Liu Z; Tian L; Zhang B; Lin CK; Kung HF; Sung JJ; He ML
Biomed Pharmacother; 2009 Nov; 63(9):658-62. PubMed ID: 18926661
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy.
Chevillard S; Lebeau J; Pouillart P; de Toma C; Beldjord C; Asselain B; Klijanienko J; Fourquet A; Magdelénat H; Vielh P
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2471-8. PubMed ID: 9815649
[TBL] [Abstract][Full Text] [Related]
14. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
16. Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population.
Tatari F; Salek R; Mosaffa F; Khedri A; Behravan J
DNA Cell Biol; 2009 May; 28(5):259-63. PubMed ID: 19388849
[TBL] [Abstract][Full Text] [Related]
17. C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.
Hur EH; Lee JH; Lee MJ; Choi SJ; Lee JH; Kang MJ; Seol M; Jang YE; Lee HJ; Kang IS; Shim SK; Ryu SG; Kang YA; Lee YS; Park CJ; Chi HS; Lee KH
Leuk Res; 2008 Oct; 32(10):1601-4. PubMed ID: 18272218
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
19. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
Orlando L; Del Curto B; Gandini S; Ghisini R; Pietri E; Torrisi R; Balduzzi A; Cardillo A; Dellapasqua S; Veronesi P; Viale G; Goldhirsch A; Colleoni M
Breast; 2008 Oct; 17(5):506-11. PubMed ID: 18456496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]